Article title

Abstract

Keywords

History of monoclonal antibodies and their path through modern medicine

The mechanisms of action of monoclonal antibodies

Pharmacokinetics, pharmacodynamics, and adverse reactions

The therapeutic spectrum of monoclonal antibodies

Monoclonal antibodies and inflammatory diseases. The new types of antibodies

Monoclonal antibodies and their use in the treatment of infectious diseases

Monoclonal antibodies and antibody-based molecules—reliable opportunity to effectively counter emerging viral pathogens and antibiotic-resistant bacteria

Nanoantibodies and infectious diseases

COVID-19 infection and monoclonal antibodies—a potentially effective therapy

The SARS-CoV-2 virus and the immune response to it

Monoclonal antibodies with a direct antiviral effect and monoclonal antibodies (mAbs) with a specific anti-inflammatory effect

SARS-CoV-2 variants of concern—emerging theories and the role of monoclonal antibodies

The fight against the “cytokine storm”

SARS-CoV-2, vaccines, monoclonal antibodies, and the appearance of new mutations

Monoclonal antibody treatment and the opportunity to provide protective immunity

Conclusion

Additional information

References